Showing results (1221-1230 of 14,091) with videos related to
Sort By:
Pageof 1,410
Gynecologic Oncology|June 9, 2009
Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancerAmer K Karam, Jing Wang Chiang, Ewina Fung, et al.Gynecologic Oncology|June 9, 2009
Comprehensive analysis of Human Papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinomaKoen D Quint, Maurits N C de Koning, Daan T Geraets, et al.Gynecologic Oncology|June 9, 2009
Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methodsChengquan Zhao, Anca Florea, Agnieszka Onisko, et al.Gynecologic Oncology|June 9, 2009
GPR30 predicts poor survival for ovarian cancerHarriet O Smith, Hugo Arias-Pulido, Dennis Y Kuo, et al.Gynecologic Oncology|March 14, 2009
Dissection of soft-preserved cadavers in the training of gynaecological oncologists: report of the first UK workshopDesmond P J Barton, D Ceri Davies, Vishy Mahadevan, et al.Gynecologic Oncology|June 13, 2009
Efficacy of pegylated liposomal doxorubicin (PLD) plus carboplatin in ovarian cancer patients who recur within six to twelve months: a phase II studyPatti Power, Gavin Stuart, Amit Oza, et al.Gynecologic Oncology|May 5, 2009
Long-term assessment of bladder and bowel dysfunction after radical hysterectomyRebecca A Brooks, Jason D Wright, Matthew A Powell, et al.Gynecologic Oncology|May 5, 2009
Pelvic exenteration: ten-year experience at the European Institute of Oncology in MilanAngelo Maggioni, Giovanni Roviglione, Fabio Landoni, et al.Gynecologic Oncology|December 27, 2008
The safety and efficacy of day 1 versus day 2 administration of pegfilgrastim in patients receiving myelosuppressive chemotherapy for gynecologic malignanciesJenny M Whitworth, Kellie S Matthews, Kimberly A Shipman, et al.Gynecologic Oncology|January 2, 2009
Intraoperative gross assessment of myometrial invasion and cervical involvement in endometrial cancer: Role of tumor grade and sizeStelios Fotiou, Nikos Vlahos, Agatha Kondi-Pafiti, et al.Pageof 1,410